Study of RNS60 on Pain and Function After Hip Labral Repair

Phase 2

Withdrawn

• Conditions: Hip Labral Tear
• Interventions: Drug: RNS60; Drug: Saline

• Registration Number: NCT02005523
• Lead Sponsor: Revalesio Corporation

Brief Summary

The purpose of this study is to see if use of RNS60 during hip labral repair surgery decreases pain and improves functional capacity post-operation.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-12-03
• Study First Submitted QC: 2013-12-06
• Study First Posted: 2013-12-09
• Primary Completion: 2014-10
• Status Verified: 2015-02
• Last Update Submitted: 2015-02-04
• Last Update Posted: 2015-02-06

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
RNS60	RNS60	-
Saline	Saline	-

Primary Outcome Measures

Name	Time	Method
Assessment of post-operative pain	1 week	Comparison of scores from validated pain scales from post-surgery to one week.